Skip to main content
. 2014 Oct 30;9(11):1868–1875. doi: 10.2215/CJN.01080114

Table 2.

Association between MeDi score and incident eGFR<60 ml/min per 1.73 m2

MeDi Score OR 
(95% CI) P 
Value
Continuous (per 1-point increase in MeDi score)
 Unadjusted 0.81 (0.72 to 0.92) 0.002
 Demographic adjusteda 0.83 (0.73 to 0.95) <0.01
 Fully adjustedb 0.83 (0.71 to 0.96) 0.02
MeDi score ≥5 (versus <5)
 Unadjusted 0.49 (0.33 to 0.75) 0.001
 Demographic adjusteda 0.49 (0.32 to 0.75) 0.001
 Fully adjustedb 0.50 (0.31 to 0.81) 0.004
MeDi quartiles (unadjusted)
 0–3 Ref
 4 1.30 (0.78 to 2.16) 0.31
 5 0.52 (0.28 to 0.95) 0.03
 6–9 0.60 (0.34 to 1.07) 0.08
MeDi quartiles (demographic adjusted)
 0–3 Ref
 4 1.44 (0.85 to 2.46) 0.18
 5 0.50 (0.27 to 0.93) 0.03
 6–9 0.67 (0.37 to 1.21) 0.18
MeDi quartiles (fully adjusted)
 0–3 Ref
 4 1.61 (0.88 to 2.97) 0.12
 5 0.51 (0.26 to 1.02) 0.06
 6–9 0.76 (0.39 to 1.46) 0.41

OR, odds ratio; 95% CI, 95% confidence interval.

a

Adjusted for age (years), sex, race (black, white, Hispanic, or other), education (high school completion versus not), and insurance status (Medicare/private insurance versus Medicaid/no insurance).

b

Adjusted for age (years), sex, race/ethnicity (black, white, Hispanic, or other), education (high school completion versus not), insurance status (Medicare/private insurance versus Medicaid/no insurance), physical activity (any exercise versus not), BMI (kg/m2), diabetes (yes or no), smoking status (never, past, or current), hypertension (yes or no), LDL (mg/dl), HDL (mg/dl), baseline eGFR (ml/min per 1.73 m2), and ACE inhibitor/ARB usage (yes or no).